Regulatory Focus

Recent ruling gives FDA ammunition against unapproved cell therapies

15 June 2021 | By Joanne S. Eglovitch

A recent appeals court decision strengthens the US Food and Drug Administration’s efforts to crack down on clinics making unapproved...

Regulatory Exchange